
Emily Miller
Articles
-
Dec 4, 2024 |
consumernotice.org | Christian Simmons |Emily Miller
Lawsuits involving Johnson & Johnson’s baby powder and its possible ties to ovarian cancer are set to remain paused for several more months. Bloomberg reported that Judge Christopher Lopez is keeping a stay on active litigation in place into March. Lopez is overseeing the bankruptcy case of Red River Talc, a J&J subsidiary. J&J formed this subsidiary to help resolve an $8 billion settlement of thousands of talcum powder lawsuits.
-
Dec 2, 2024 |
consumernotice.org | Christian Simmons |Emily Miller
Two major PFAS lawsuit settlements are now set to move forward. Federal Judge Richard Gergel gave the final approval on Friday for a $750 million settlement involving Tyco Fire Products and a $316.5 million settlement involving BASF Corporation, determining that both payouts were “fair, reasonable, and adequate.”Both settlements will resolve claims of contamination involving per- and polyfluoroalkyl substances (PFAS), also known as forever chemicals.
-
Dec 2, 2024 |
consumernotice.org | Christian Simmons |Emily Miller
Roundup lawsuits continue to go to trial in Pennsylvania court, with recent wins for both sides. Monsanto won the latest trial, which ended last week. In that case, a woman had blamed her non-Hodgkin lymphoma on the weed killer after using it for several years before her diagnosis. That trial marked the 15th win in the last 22 trials for Bayer, which acquired Monsanto in 2018, but it has been far from a perfect run for the company.
-
Nov 20, 2024 |
consumernotice.org | Christian Simmons |Emily Miller
The latest Roundup lawsuit to go to trial has ended in a victory for the defendants, as mixed results continue in the litigation. According to Law.com, plaintiff Judith Womack developed non-Hodgkin lymphoma after using Roundup regularly for several years. She blamed the development of her cancer on her exposure to the weed killer. For years, Roundup has been tied to the development of cancer. But a Philadelphia jury on Friday sided with Monsanto, the company behind Roundup.
-
Nov 18, 2024 |
consumernotice.org | Christian Simmons |Emily Miller
Within months of being pulled from the market and halting clinical trials, Oxbryta, a sickle cell treatment drug, is now facing a lawsuit. The case, which was filed in California, claims that the makers of the drug failed to warn about serious adverse health effects tied to its use. Tirrell Allen, the plaintiff in the lawsuit, started taking Oxbryta in August after dealing with sickle cell for most of his life.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →